Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

AndrewHarper924 Aug. 18 at 11:39 AM

$CVNA $PFE $FIG $XOM Carvana benefits from used-car demand and financing conditions, Pfizer remains focused on pharmaceutical demand and pipeline development, FIG remains execution-dependent, and Exxon Mobil remains leveraged to oil and gas prices. I'm watching used-car prices, clinical catalysts, funding, and energy prices.

0 · Reply

CB3000Calls Aug. 18 at 11:31 AM

$SLS super interesting timing for $PFE CEO to do this especially with SLS in a quiet period and we all know the connections these two have. If you are the CEO of PFE and you are winning the bid for SLS and you know you basically have the best cure/treatment coming for all WT1 cancers, yeah you are buying a lot of your own shares.

4 · Reply

JTE_Theta Aug. 18 at 10:29 AM

$PFE CEO just bought $1M of his own stock first open market buy since becoming CEO in 2019. Stock’s down 55%+ from ATH but just posted a beat and raise. Insider conviction + 6%+ yield + <10x fwd earnings… watching this one. Not touching size yet but it’s on my radar for a wheel candidate.

0 · Reply

LLLJJJ Aug. 18 at 10:06 AM

$PFE Pfizer's weight loss drug, Berobenatide / MET-097, if launched in 2028, should go to the moon.

0 · Reply

TradeAtlas Aug. 18 at 6:09 AM

0 · Reply

TopTierNewswire Aug. 18 at 5:44 AM

$PFE "Pfizer CEO's $1M insider buy and positive news sentiment confirm strong conviction in the name, with the stock outperforming its sector and printing fresh intraday highs." - From the Top Tier Newswire AI model.

0 · Reply

USAEquityResearch Aug. 18 at 4:13 AM

$PFE 📊 USAEquityResearch ▼ nan (nan%) Trend: Cautiously bearish ↘️ RSI (14): nan — neutral territory MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: nan Support: nan 20-MA: nan | 50-MA: nan Educational content only. Not financial advice.

0 · Reply

taxplanr Aug. 18 at 3:29 AM

mRNA trials for autoimmune diseases caused cancer and heart problems $BNTX $MRNA $PFE https://www.instagram.com/reel/DcHa3IcKUAE/?igsh=MTB0anJrYXAzc2QyeA==

0 · Reply

peloswing Aug. 18 at 2:20 AM

$PFE has a Date with $30 if this iH&S neckline breaks!

3 · Reply

CapitalMonk Aug. 18 at 1:04 AM

$PFE Price: $26.87 (+0.30%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 71.3 | Momentum: Moderate Volume: -38.2% vs avg Volatility: 1.12% Support: $24.23 | Resistance: $27.20 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 3 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 3 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 3 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 3 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 3 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 4 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

2026-08-07T11:40:49.000Z - 11 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 11 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 13 days ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 13 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 14 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 14 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 14 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 14 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 14 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 19 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 19 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 19 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 26 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 26 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 27 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 4 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 7 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 7 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 7 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 7 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

AndrewHarper924 Aug. 18 at 11:39 AM

0 · Reply

CB3000Calls Aug. 18 at 11:31 AM

4 · Reply

JTE_Theta Aug. 18 at 10:29 AM

0 · Reply

LLLJJJ Aug. 18 at 10:06 AM

$PFE Pfizer's weight loss drug, Berobenatide / MET-097, if launched in 2028, should go to the moon.

0 · Reply

TradeAtlas Aug. 18 at 6:09 AM

0 · Reply

TopTierNewswire Aug. 18 at 5:44 AM

0 · Reply

USAEquityResearch Aug. 18 at 4:13 AM

0 · Reply

taxplanr Aug. 18 at 3:29 AM

mRNA trials for autoimmune diseases caused cancer and heart problems $BNTX $MRNA $PFE https://www.instagram.com/reel/DcHa3IcKUAE/?igsh=MTB0anJrYXAzc2QyeA==

0 · Reply

peloswing Aug. 18 at 2:20 AM

$PFE has a Date with $30 if this iH&S neckline breaks!

3 · Reply

CapitalMonk Aug. 18 at 1:04 AM

0 · Reply

JuggernautRaider Aug. 17 at 11:18 PM

$TNXP $NUVB $BMY $PFE four amazing biotech companies. They need help but I can no longer post much due to a contract i signed. Good luck, and God Bless! 😘 ☘️ 🙏 🇺🇸 ⚡️ 🚀 🇵🇱 👊 🤜 💎 💥 🤯 🧠 🤕 🤢 🤮 😮‍💨 😅 👍 ✌️ ♋️ Cheers, old mates and @Stocktwits stalkers! You are On your Own. 🫡 ⚓️ 🚘 I am going on vacation to Poland. Wish me luck! 😝 🇺🇦 SLAVA UKRAINE!!! And Viva la Raza. Bienvenidos a America, mis amigas y amigos. We need you!

0 · Reply

ShibWillow Aug. 17 at 9:21 PM

Looks like Volume is shifting to MLEC now 🚀 MLEC has 573k shares remaining to public Look at what WETO / IPST did on similar share numbers today. MLEC getting squeezed now - Added a big position for a parabolic run! $DNN $DNUT $SOUN $PFE pr

0 · Reply

LoneBroker Aug. 17 at 9:12 PM

$PLTR $HPE $PFE

0 · Reply

JimmyOcarri Aug. 17 at 8:24 PM

$EYPT $PYPL $PFE $CEG $RXRX p

0 · Reply

clan Aug. 17 at 6:48 PM

$MNKD @neil36 @MrMulally @MayorofMNKD I wonder if the CEO of Mannkind could, or would, atleast hint at, or fully disclose, the names of the drug companies with which Mannkind has had recent discussions regarding collaborations putting their drug on Technosphere. Maybe, ... sounds-like-Lasagna🍝 just needs to be asked the question, in the right way, at the right time. #technosphere $PFE 🤔 $MRK 🤔 $AZN 🫵

1 · Reply

Silver3urfer_Trader Aug. 17 at 6:33 PM

$KHC $VICI opportunities here again. I made a nice $2K+ last week trading these. Keep a close eye on them. $SIRI paid a nice 2.00% nice. $PFE $VZ a little high, waiting for some resistance to see the play later on. Good luck out there in the world of stock investors/traders.

0 · Reply

jaqr Aug. 17 at 6:20 PM

$PFE $3MM in inside purchase, who else is doing that?

0 · Reply

jaqr Aug. 17 at 6:06 PM

$PFE So even the CEO bought $1MM last week? I had no idea about it, is there any rules where they must purchase X amount of days before any material announcement? i wonder if they are preparing to announce something with $3MM of insider purchase in less than 2 weeks

1 · Reply

Jack90 Aug. 17 at 5:03 PM

$NKE $PFE $VZ I like dividend

1 · Reply

Micheal_Pothead Aug. 17 at 5:01 PM

$PFE 27 is poison now… It’s an improvement

1 · Reply

reyofhope Aug. 17 at 4:51 PM

$PFE when do we moon?

1 · Reply

1hawk Aug. 17 at 3:31 PM

$PFE got to assume this will go down after divy payment next month

3 · Reply

Market Cap	152.69B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.79
Forward PE	9.00
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	29,261,200
Avg Vol	44,206,129
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	83%
Beta	0.34
Analysts	Sell
Price Target	$28.60